In the SmartfIRE study, the Thermocool Smarttouch SF catheter showed an 86.9% effectiveness rate among patients treated with high adherence to recommended ablation parameters.

News & events \| $7 million awarded to establish Australia’s first atrial fibrillation ablation clinical quality registry; $7 million awarded to establish Au ...

Research finds adults under 70 with atrial fibrillation have 21% higher dementia risk, with onset cases showing a dramatic 36 ...

Atrial fibrillation independently increases dementia risk by 21% in adults under the age of 70, new research indicates.

Pulsed field ablation (PFA) was noninferior to cryoballoon ablation for the incidence of a first recurrence of atrial ...

A ground-breaking step to improve cardiac care in Australia has been taken, as funding is announced for a clinical quality registry to improve ...

Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

TidalHealth Peninsula Regional is now the first in the area to offer the innovative robotic convergent procedure ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

This 2025 guide features leading specialists in geriatrics, cardiology, oncology, cosmetic dentistry and cutting-edge ...

With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that ...